UNITY Biotechnology, Inc. Reports Second Quarter 2020 Financial Results and Clinical Program Updates
31 juil. 2020 07h57 HE
|
Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., July 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing,...
UPDATE – UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results
29 juil. 2020 16h05 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, July 29, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results
24 juil. 2020 08h00 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, July 24, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY Biotechnology Announces CFO Transition
06 juil. 2020 17h00 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, July 06, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. Provides Updates on Lead Development Programs
01 juil. 2020 16h05 HE
|
Unity Biotechnology, Inc.
– Topline 12-week results for Phase 2 study of UBX0101 in osteoarthritis expected in 3Q 2020 – – First-in-human study for UBX1325 in age-related eye disease expected to commence in 2H 2020 – SOUTH...
UNITY Biotechnology to Participate in Fireside Chat at the Goldman Sachs 41st Annual Global Healthcare Conference
11 juin 2020 14h31 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, June 11, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY Biotechnology to Participate in the Goldman Sachs 41st Annual Global Healthcare Conference
28 mai 2020 16h05 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, May 28, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY Biotechnology, Inc. Reports First Quarter 2020 Financial Results and Business Updates
07 mai 2020 16h05 HE
|
Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting...
UNITY Biotechnology, Inc. to Announce First Quarter 2020 Financial Results
04 mai 2020 16h30 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, May 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY Biotechnology Completes Enrollment in Phase 1b Study of UBX0101
31 mars 2020 16h05 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, March 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...